NCT00405119View on ClinicalTrials.gov

A Study To Investigate The Effectiveness Of AH234844 (Lavoltidine) Compared With NEXIUM And Ranitidine.

PHASE2CompletedINTERVENTIONAL

Enrollment

92

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions

Gastroesophageal Reflux DiseaseReflux, Gastroesophageal

Interventions

DRUG

AH23844 (lavoltidine)

DRUG

NEXIUM (esomeprazole)

DRUG

ZANTAC (ranitidine)

Trial Locations (2)

2031

GSK Investigational Site, Randwick

4006

GSK Investigational Site, Herston

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY